Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dietary Supplement GMP Spin-Off Reg May Address Small Business Impact

This article was originally published in The Tan Sheet

Executive Summary

The Office of Management and Budget on May 23 completed reviewing an interim final rule related to dietary supplement good manufacturing practices FDA is expected to publish within six weeks, according to OMB.

You may also be interested in...



Dietary Supplement GMPs Back To FDA; Publication Expected In June

Dietary supplement good manufacturing practices have received final clearance by the Office of Management and Budget, OMB and FDA confirmed May 9

GMP Cost Impact, Ephedra Suits Loom Over Supplement Industry – Israelsen

The Office of Management & Budget likely is delayed in releasing GMPs because it is grappling with issues surrounding the economic impact of the rule on small businesses, according to UNPA head Loren Israelsen

Dietary Supplement GMP Roundtable

Six top industry insiders recently shared with "The Tan Sheet" their thoughts on the pending release of FDA's final rule on dietary supplement Good Manufacturing Practices. The participants were: Scott Bass of the law firm Sidley Austin Brown & Wood; Council for Responsible Nutrition President Annette Dickinson, PhD; Utah Natural Products Alliance Executive Director Loren Israelsen; American Herbal Products Association President Michael McGuffin; U.S. Pharmacopeia Director-Dietary Supplements David Roll, PhD; and National Nutritional Foods Association Executive Director & CEO David Seckman.

Related Content

Topics

UsernamePublicRestriction

Register

PS100542

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel